136 related articles for article (PubMed ID: 38240497)
21. CRISPR/Cas9 mediated high efficiency knockout of the eye color gene Vermillion in Helicoverpa zea (Boddie).
Perera OP; Little NS; Pierce CA
PLoS One; 2018; 13(5):e0197567. PubMed ID: 29771955
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-responsive release of Cas9/sgRNA from DNA nanoflower for cytosolic protein delivery and enhanced genome editing.
Shi J; Yang X; Li Y; Wang D; Liu W; Zhang Z; Liu J; Zhang K
Biomaterials; 2020 Oct; 256():120221. PubMed ID: 32738651
[TBL] [Abstract][Full Text] [Related]
23. Delivering Cas9/sgRNA ribonucleoprotein (RNP) by lentiviral capsid-based bionanoparticles for efficient 'hit-and-run' genome editing.
Lyu P; Javidi-Parsijani P; Atala A; Lu B
Nucleic Acids Res; 2019 Sep; 47(17):e99. PubMed ID: 31299082
[TBL] [Abstract][Full Text] [Related]
24. Delivery Aspects of CRISPR/Cas for in Vivo Genome Editing.
Wilbie D; Walther J; Mastrobattista E
Acc Chem Res; 2019 Jun; 52(6):1555-1564. PubMed ID: 31099553
[TBL] [Abstract][Full Text] [Related]
25. LNP-mediated delivery of CRISPR RNP for wide-spread in vivo genome editing in mouse cornea.
Mirjalili Mohanna SZ; Djaksigulova D; Hill AM; Wagner PK; Simpson EM; Leavitt BR
J Control Release; 2022 Oct; 350():401-413. PubMed ID: 36029893
[TBL] [Abstract][Full Text] [Related]
26. Folate Receptor-Mediated Delivery of Cas9 RNP for Enhanced Immune Checkpoint Disruption in Cancer Cells.
Lin Y; Wilk U; Pöhmerer J; Hörterer E; Höhn M; Luo X; Mai H; Wagner E; Lächelt U
Small; 2023 Jan; 19(2):e2205318. PubMed ID: 36399647
[TBL] [Abstract][Full Text] [Related]
27. Development of ionizable lipid nanoparticles and a lyophilized formulation for potent CRISPR-Cas9 delivery and genome editing.
Sun Q; Zhang H; Ding F; Gao X; Zhu Z; Yang C
Int J Pharm; 2024 Mar; 652():123845. PubMed ID: 38266942
[TBL] [Abstract][Full Text] [Related]
28. Rapid, Selection-Free, High-Efficiency Genome Editing in Protozoan Parasites Using CRISPR-Cas9 Ribonucleoproteins.
Soares Medeiros LC; South L; Peng D; Bustamante JM; Wang W; Bunkofske M; Perumal N; Sanchez-Valdez F; Tarleton RL
mBio; 2017 Nov; 8(6):. PubMed ID: 29114029
[TBL] [Abstract][Full Text] [Related]
29. Efficient genome editing in Fusarium oxysporum based on CRISPR/Cas9 ribonucleoprotein complexes.
Wang Q; Cobine PA; Coleman JJ
Fungal Genet Biol; 2018 Aug; 117():21-29. PubMed ID: 29763675
[TBL] [Abstract][Full Text] [Related]
30. Biomimetic Mineralized CRISPR/Cas RNA Nanoparticles for Efficient Tumor-Specific Multiplex Gene Editing.
Liang Y; Zhang J; Xu C; Wang J; Han W; Yang J; Wu S; An J; Liu J; Zhang Z; Shi J; Zhang K
ACS Nano; 2023 Aug; 17(15):15025-15043. PubMed ID: 37481734
[TBL] [Abstract][Full Text] [Related]
31. Codelivery of CRISPR-Cas9 and chlorin e6 for spatially controlled tumor-specific gene editing with synergistic drug effects.
Deng S; Li X; Liu S; Chen J; Li M; Chew SY; Leong KW; Cheng D
Sci Adv; 2020 Jul; 6(29):eabb4005. PubMed ID: 32832641
[TBL] [Abstract][Full Text] [Related]
32. Genome Editing in Penicillium chrysogenum Using Cas9 Ribonucleoprotein Particles.
Pohl C; Mózsik L; Driessen AJM; Bovenberg RAL; Nygård YI
Methods Mol Biol; 2018; 1772():213-232. PubMed ID: 29754231
[TBL] [Abstract][Full Text] [Related]
33. Bi-functionalized aminoguanidine-PEGylated periodic mesoporous organosilica nanoparticles: a promising nanocarrier for delivery of Cas9-sgRNA ribonucleoproteine.
Salekdeh PR; Ma'mani L; Tavakkoly-Bazzaz J; Mousavi H; Modarressi MH; Salekdeh GH
J Nanobiotechnology; 2021 Mar; 19(1):95. PubMed ID: 33789675
[TBL] [Abstract][Full Text] [Related]
34. Genome editing of mutant KRAS through supramolecular polymer-mediated delivery of Cas9 ribonucleoprotein for colorectal cancer therapy.
Wan T; Chen Y; Pan Q; Xu X; Kang Y; Gao X; Huang F; Wu C; Ping Y
J Control Release; 2020 Jun; 322():236-247. PubMed ID: 32169537
[TBL] [Abstract][Full Text] [Related]
35. A stable DNA-free screening system for CRISPR/RNPs-mediated gene editing in hot and sweet cultivars of Capsicum annuum.
Kim H; Choi J; Won KH
BMC Plant Biol; 2020 Oct; 20(1):449. PubMed ID: 33004008
[TBL] [Abstract][Full Text] [Related]
36. Efficient Multi-Allelic Genome Editing of Primary Cell Cultures via CRISPR-Cas9 Ribonucleoprotein Nucleofection.
Hoellerbauer P; Kufeld M; Paddison PJ
Curr Protoc Stem Cell Biol; 2020 Sep; 54(1):e126. PubMed ID: 32833346
[TBL] [Abstract][Full Text] [Related]
37. Rationally designed nanoparticle delivery of Cas9 ribonucleoprotein for effective gene editing.
Chae SY; Jeong E; Kang S; Yim Y; Kim JS; Min DH
J Control Release; 2022 May; 345():108-119. PubMed ID: 35247491
[TBL] [Abstract][Full Text] [Related]
38. Chemical Evolution of Amphiphilic Xenopeptides for Potentiated Cas9 Ribonucleoprotein Delivery.
Lin Y; Luo X; Burghardt T; Dorrer S; Höhn M; Wagner E; Lächelt U
J Am Chem Soc; 2023 Jul; 145(28):15171-15179. PubMed ID: 37395536
[TBL] [Abstract][Full Text] [Related]
39. Targeting Noncoding RNA Domains to Genomic Loci with CRISPR-Display: Guidelines for Designing, Building, and Testing sgRNA-ncRNA Expression Constructs.
Shechner DM
Methods Mol Biol; 2021; 2162():115-152. PubMed ID: 32926381
[TBL] [Abstract][Full Text] [Related]
40. Highly efficient genome editing via CRISPR-Cas9 ribonucleoprotein (RNP) delivery in mesenchymal stem cells.
Han AR; Shin HR; Kwon J; Lee SB; Lee SE; Kim EY; Kweon J; Chang EJ; Kim Y; Kim SW
BMB Rep; 2024 Jan; 57(1):60-65. PubMed ID: 38053293
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
